| | | | | | | | | | |
|
|
| Dockets Entered On November 08, 2006
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 2006D-0344
|
| Guidance for Industry on Drug Interaction Studies--Study Design, Data Analysis, and Implications for Dosing and Labeling
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
| 2006M-0455
|
| P020012 - ArteFill
|
|
|
| 2006M-0456
|
| P050022 - syngo Lung CAD
|
|
|
| 2006M-0457
|
| P040050 - Macroplastique Implants
|
|
|
| 2006N-0292
|
| Unique Device Identification
|
|
|
| 2006N-0432
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on How to Use E-mail to Submit Information to the Center for Veterinary Medicine
|
|
|
| 2006N-0434
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance For Industry On How To Use E-Mail To Submit A Request For A Meeting Or Teleconference To The Office Of New Anim
|
|
|
|
|
|
| 2006N-0435
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Notice of Intent to Slaughter for Human Food Purposes
|
|
|
|
| 2006N-0436
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit A Study Protocol
|
|
|
| 2006P-0096
|
| Regarding the following non-binding package requirement for a minimum of - 1/8 inch holes in each package of mushrooms
|
|
|
| 2006P-0154
|
| remove from the market, the prescription version of Xenical (orlistat,Roche Pharmaceuticals)
|
|
|
| 2006D-0344
|
| Guidance for Industry on Drug Interaction Studies--Study Design, Data Analysis, and Implications for Dosing and Labeling
|
|
|
| C 1
|
| Pharmaceutical Research and Manufacturers of America (PhRMA)
|
| Vol #:
|
| 1
|
|
|
| 2006D-0383
|
| Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
|
|
|
|
|
|
|
| C 16
|
| R. Liwanag
|
| Vol #:
|
| 1
|
|
|
| 2006M-0455
|
| P020012 - ArteFill
|
|
|
| AAV 1
|
| Artes Medical USA, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2006M-0456
|
| P050022 - syngo Lung CAD
|
|
|
| AAV 1
|
| Siemens Medical Solution USA, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2006M-0457
|
| P040050 - Macroplastique Implants
|
|
|
| AAV 1
|
| Uroplasty, Inc.
|
| Vol #:
|
| 1
|
|
|
| 2006N-0292
|
| Unique Device Identification
|
|
|
| C 3
|
| Hand Held Products, Inc. (Hand Held)
|
| Vol #:
|
| 3
|
|
|
| C 4
|
| Cardinal Health
|
| Vol #:
|
| 3
|
|
|
| 2006N-0432
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on How to Use E-mail to Submit Information to the Center for Veterinary Medicine
|
|
|
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006N-0434
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance For Industry On How To Use E-Mail To Submit A Request For A Meeting Or Teleconference To The Office Of New Anim
|
|
|
|
|
|
| | | | | | | | |
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006N-0435
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit a Notice of Intent to Slaughter for Human Food Purposes
|
|
|
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006N-0436
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on How to Use E-Mail to Submit A Study Protocol
|
|
|
| N 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006P-0096
|
| Regarding the following non-binding package requirement for a minimum of - 1/8 inch holes in each package of mushrooms
|
|
|
| LET 1
|
| FDA/CFSAN to Monterey Mushrooms Inc.
|
| Vol #:
|
| 1
|
|
|
| 2006P-0154
|
| Remove from the market, the prescription version of Xenical (orlistat,Roche Pharmaceuticals)
|
|
| C 2
|
| GlaxoSmithKline Consumer Healthcare (GSK) and Hoffmann-LaRoche, Inc. (Roche)
|
| Vol #:
|
| 3
|
|